多级射频消融联合化疗粒子治疗原发性肝癌  

Percutaneous radiofrequency ablation combined with interstitial chemotherapy for primary hepatic cancer

作　　者：朱彤[1] 陈涛[1] 胡志前[2] 

机构地区：[1]上海市第八人民医院普通外科,上海200235 [2]第二军医大学附属长征医院普通外科,上海200003

出　　处：《中国普通外科杂志》2007年第7期675-677,共3页China Journal of General Surgery

摘　　要：目的 探讨多级射频消融（RF） 联合化疗粒子对肝癌的治疗作用.方法 回顾性分析52例原发性肝癌采用B超引导下RF联合化疗粒子的治疗方法和效果.结果 全组无严重并发症或死亡者.50例（96.2 %）随访24～48个月,84.7 %患者自觉症状明显改善,57.7 %的AFP值下降.术后1,2,3,4年生存率分别为 92 %, 78 %,56 %,34 %.结论 RF联合化疗粒子是治疗肝癌新的安全可靠有效的方法.Objective To study the efficacy and indications of percutaneous radiofrequency ablation combined with interstitial chemotherapy for primary liver cancer. Methods The clinical data of 52 cases with primary liver cancer treated by percutaneous radiofrequency combined with interstitial chemotherapy were analysed retrospectively. Results Symptoms were significantly ameliorated in 85 % of the patients. After the treatment, AFP level declined in 58 % of the patients. The postoperative 1-, 2-, 3-,4-year surrival rate were 92 % , 78 % , 56 % , 43 % , respectively. Conclusions Pereutaneous radiofrequency ablation combined with interstitial chemotherapy is a new safe, reliable and effective method for management of liver cancer.

关 键 词：肝肿瘤/治疗 多射频消融 化疗粒子 

分 类 号：R735.7[医药卫生—肿瘤]